Navigation Links
Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery
Date:5/7/2009

currence and provide reassurance to patients who live with the realities of GIST."

Glivec is now licensed to be used to treat patients at significant risk of relapse following the removal of their tumour following approval from the European Medicines Agency (EMEA). The EMEA (the body responsible for the scientific evaluation of applications for European authorisation for medicinal products) says that patients who have a low or very low risk of recurrence should not receive adjuvant treatment.(1)

What is GIST?

GIST is a type of cancer called a soft tissue sarcoma i.e. a cancer of a supportive or connective tissue in the body such as fat, muscle, blood vessels, deep skin tissues, nerves, bones and cartilage.(8) GISTs develop primarily along the gastrointestinal tract (digestive system) and often spread within the abdomen.(9)

Although the cause of GIST is unknown,(10) 75-80% of people with GIST carry KIT mutations.(11) KIT is a protein in the body that plays an important role in the growth and survival of GIST.(12) In patients with GIST, the KIT protein can mutate and become over active.(5)

The normal role of KIT is to provide the 'signal' to cells in the body to grow and divide: this signal is not given continuously but can be turned 'on' and 'off' to limit cell division and growth. However, in people with GIST, a mutation in the DNA causes KIT to be continuously activated. Left 'on' all the time, KIT signals to cells to constantly grow and divide, driving the growth of GIST.(5)

Glivec in GIST

Glivec is a type of treatment called a tyrosine kinase inhibitor.(13) It works in GIST by targeting the KIT protein, binding to it and preventing it from sending continuous signals to the cancer cells to grow and divide.(14) Glivec has been available to treat people with unresectable GIST (GIST that cannot be removed through surgery) since 2002, but currently m
'/>"/>

SOURCE Novartis Oncology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
2. Bionovo Announces First Quarter 2009 Highlights and Financial Results
3. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
4. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
5. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
6. Transcept Pharmaceuticals to Report First Quarter 2009 Results
7. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
8. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
9. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
10. First Candidate from Esperances Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept
11. Oakwood Surgeons Perform Worlds First 3D Surgery Without Special Glasses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 Valeant Pharmaceuticals ... ) (TSX: VRX) today announced the ... its 2013 annual meeting of shareholders ... vote for the election of directors ... Farmer235,731,9341,964,748Robert A. Ingram233,865,8763,830,806Theo Melas-Kyriazi237,081,508615,174G. Mason Morfit235,623,2832,073,399J. ...
(Date:5/21/2013)... EAST TAUNTON, Massachusetts , 21 de mayo de ... Synergy, Inc. ("OSI"), cuyas compañías filiales incluyen OMNIlife ... a dos directores experimentados para su junta. Guy Mayer, ... junta directiva y David Johnson ... unirá como director. Antes de unirse ...
(Date:5/21/2013)... and PHILADELPHIA , May 21, 2013 ... its new corporate image and impressive new product developments at ... . "After ten years of unerring focus on product ... felt the need to mark the occasion," said founding director ... we have some interesting developments of benefit to our clients ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3
(Date:5/22/2013)... from a large observational study reported at ... superior to heparin in the absence of ... patients with non-ST segment elevation acute coronary ... European and US NSTE-ACS guidelines currently recommend ... heparin plus GP IIb/IIIa receptor inhibitors in ...
(Date:5/22/2013)... MA (PRWEB) May 22, 2013 In ... hit the country’s fields and courts with donated ... Sports, a Massachusetts-based nonprofit dedicated to partnering with manufacturers ... is celebrating the donation of $8.8 million in sports ... more than a half-million kids outfitted for physical activity. ...
(Date:5/22/2013)... Following the success of last year’s ... Fit Body Boot Camp Kincardine has announced it will ... starting on June 3rd at its Kincardine fitness ... Kincardine, Ontario.     , Fit Body Boot Camp’s 1,000 lb. ... community residents to lose a total of 1,000 pounds ...
(Date:5/22/2013)... Jersey City, NJ (PRWEB) May 22, 2013 ... governance, compliance, and management solutions for social enterprise ... Partners, LLC, a consulting firm based in Chicago, ... to integrate their products and provide best-in-class solutions ... productivity and improve collaboration. , AvePoint’s DocAve ...
(Date:5/22/2013)... adherence to appropriate medication therapy has been shown to ... 125,000 deaths in the U.S. every year are attributed ... estimated that between 33% and 69% of all medication-related ... a reality that costs the American health-care system approximately ... degree of medication non-adherence — and the consequences therefrom ...
Breaking Medicine News(10 mins):Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2
... 25 Former NFL player and Dallas Cowboy,Jason Kaiser ... graduation ceremony. Kaiser earned the title of,valedictorian with a ... people in,this school and in my class especially," he ... Before enrolling in Parker College, Kaiser played professional football,for ...
... protein levels could key future treatments for Alzheimer,s , , ... finds that where protein-destroying machines reside in the brain,s ... a finding that may play a role in future ... Wake Forest University School of Medicine researchers studying mice ...
... his left eyebrow was possibly skin cancer , , FRIDAY, ... during his lifetime, historians have gone to great lengths ... of Franklin Delano Roosevelt, the 32nd president of the ... and heart disease is now well-documented. But a new ...
... QLT Inc. (NASDAQ: QLTI;,TSX: QLT) today reported financial results ... otherwise, all amounts are in U.S. dollars,and in accordance ... 2008, we were pleased to report the U.S. Food,and ... blood,monitoring from the Aczone(TM) label," said Bob Butchofsky, President ...
... Inc., (a wholly owned,subsidiary of Mentice AB), a ... the field of medicine, has recently appointed,Jeff Sirek ... Clinical,Applications Manager for the Americas., Jeff Sirek ... years with GE Healthcare in its Cardiovascular Ultrasound,Division ...
... Solutions, Inc. announced,today the addition of Dr. Marc ... serve as Vice President of Research and Development ... of spine,system/orthopedic development experience, most recently having directed,development ... Marc to Facet Solutions bolsters an already great,team, ...
Cached Medicine News:Health News:Former Dallas Cowboy Honored as Parker College of Chiropractic Top 2008 Graduate 2Health News:Former Dallas Cowboy Honored as Parker College of Chiropractic Top 2008 Graduate 3Health News:When It Comes to Memory, It's All About Location 2Health News:FDR Might Have Had Melanoma 2Health News:FDR Might Have Had Melanoma 3Health News:FDR Might Have Had Melanoma 4Health News:QLT announces first quarter results for 2008 2Health News:QLT announces first quarter results for 2008 3Health News:QLT announces first quarter results for 2008 4Health News:QLT announces first quarter results for 2008 5Health News:QLT announces first quarter results for 2008 6Health News:QLT announces first quarter results for 2008 7Health News:QLT announces first quarter results for 2008 8Health News:QLT announces first quarter results for 2008 9Health News:QLT announces first quarter results for 2008 10Health News:QLT announces first quarter results for 2008 11Health News:QLT announces first quarter results for 2008 12Health News:QLT announces first quarter results for 2008 13Health News:QLT announces first quarter results for 2008 14Health News:Mentice, Inc. Expands Its North American Sales and Clinical Presence With the Hiring of Jeff Sirek as Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas. 2Health News:Facet Solutions, Inc. Expands Executive Management Team 2
... is a fully automatic fluorescence photomicrography system ... of even the most difficult specimens. Designed ... PM20 system provide solution to the complex ... their automatic exposure control, the system utilizes ...
... in the PM series is designed ... for routine brightfield observation, both in ... Remarkably economical in,price, it offers a ... which meet the needs of todays ...
... camera system for high resolution photomicrography. The ... of the highest color fidelity, resolution and ... expect perfect images due to many unique ... innovative readout modes. The Leica DFC480 is ...
This compact photomicrographic system assures simple operation to achieve the exposure accuracy required for sophisticated photomicrography in most research and clinical environments....
Medicine Products: